Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 9419334 results
Sort by: relevance publication year

Vaccine equity and access: A comparative assessment of Covaxin, Covishield, and Sputnik V.

JOURNAL ARTICLE published 28 July 2023 in Indian Journal of Pharmacy and Pharmacology

Authors: Avinash Teli | Pooja Rathore | Rohit Kumar | Mohammad Shamshir Alam

https://doi.org/10.18231/j.ijpp.2023.018 Actions

Mixing of the COVID-19 vaccines Covishield and Covaxin for safety assessment

DATASET published in http://isrctn.com/

Authors: Bhanu Prakash Reddy Attunuru

https://doi.org/10.1186/isrctn98052401 Actions

The occurrence of adverse events following immunization after first and/or second dose of Covishield or Covaxin vaccine at a tertiary care hospital: An observational study

JOURNAL ARTICLE published 28 February 2022 in International Journal Of Community Medicine And Public Health

Authors: Vinay Kumar | Vandana Kashyap | A. G. Shenoy

https://doi.org/10.18203/2394-6040.ijcmph20220705 Actions

Comparative Evaluation of Short-term Clinical Safety and Efficacy of COVID-19 Vaccines - Covishield and Covaxin

JOURNAL ARTICLE published 16 March 2022 in Journal of Communicable Diseases

Authors: Abinaya Elango | Assistant Professor, Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam-603103, Chengalpattu (Dt), Tamil Nadu, India.

https://doi.org/10.24321/0019.5138.202207 Actions

SURVEY ON POST VACCINATION REACTIONS IN INDIANS AFTER COVAXIN AND COVISHIELD VACCINATION

JOURNAL ARTICLE published 1 July 2022 in International Journal of Biology, Pharmacy and Allied Sciences

https://doi.org/10.31032/ijbpas/2022/11.7.6227 Actions

Humoral Antibody Kinetics with ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) Vaccine among Indian Healthcare workers: A 6-month Longitudinal Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study

POSTED CONTENT published

Authors: Awadhesh Kumar Singh | Sanjeev Ratnakar Phatak | Ritu Singh | Kingshuk Bhattacharjee | Nagendra Kumar Singh | Arvind Gupta | Arvind Sharma

https://doi.org/10.1101/2022.02.03.22270182 Actions

Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

JOURNAL ARTICLE published December 2022 in Maxillofacial Plastic and Reconstructive Surgery

Authors: Behzad Houshmand | Seied Omid Keyhan | Hamid Reza Fallahi | Shaqayeq Ramezanzade | Erfan Sadeghi | Parisa Yousefi

https://doi.org/10.1186/s40902-021-00330-6 Actions

Safety and Immunogenicity of Combination of Vaccines – Covishield and Covaxin – a Pilot Study

POSTED CONTENT published

Authors: Bhanu Prakash Reddy Attunuru | Podduturi Naveenchander Reddy | Sasikala Mitnala | Gujjarlapudi Deepika | Sadhana Yelamanchili Veturi | Duvvur Nageshwar Reddy

https://doi.org/10.21203/rs.3.rs-1210542/v1 Actions

Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield

JOURNAL ARTICLE published 2022 in One Health Bulletin

Authors: Ayush Kumar | Shweta Shrivastava | Prashant Tiwari

https://doi.org/10.4103/2773-0344.347378 Actions

Myths and Perception of Management Students and Faculty towards Covaxin and Covishield Vaccines, Vijayawada, Andhra Pradesh

JOURNAL ARTICLE published 30 September 2021 in Journal of Pharmaceutical Research International

Authors: B. Kishore Babu | A. Yashwanth Reddy

https://doi.org/10.9734/jpri/2021/v33i45a32731 Actions

De Novo Minimal Changes Disease Associated to Inoculation with Adenovirus Vector Vaccine (Sputnik V)

JOURNAL ARTICLE published 5 January 2022 in Advancements in Journal of Urology and Nephrology

https://doi.org/10.33140/ajun.04.01.01 Actions

Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD <sup>TM</sup>) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD <sup>TM</sup> or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

JOURNAL ARTICLE published in SSRN Electronic Journal

Authors: Winsley Rose | Reshma Raju | Sudhir Babji | Anna George | Ramya Madhavan | Julian Vivek Leander Xavier | Jenita Sharon David Chelladurai | Origanti Sharon Nikitha | Arpitha Anbu Deborah | Shalini Vijayakumar | Sushil Immanuel | Jacob John | Priscilla Rupali | Kundavaram Paul Prabhakar Abhilash | Venkata Raghava Mohan | Karthik Bharadwaj Tallapaka | Prasanna Samuel | Gagandeep Kang

https://doi.org/10.2139/ssrn.4143699 Actions

Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin

JOURNAL ARTICLE published 29 December 2021 in Journal of Travel Medicine

Authors: Rajni Kant | Gaurav Dwivedi | Kamran Zaman | Rima R Sahay | Gajanan Sapkal | Himanshu Kaushal | Dimpal A Nyayanit | Pragya D Yadav | Gururaj Deshpande | Rajeev Singh | Sandeep Chaowdhary | Nivedita Gupta | Sanjay Kumar | Priya Abraham | Samiran Panda | Balram Bhargava

https://doi.org/10.1093/jtm/taab166 Actions

Safety and Immunogenicity of Mix-Match of Vaccines -Covishield and Covaxin – a Pilot Study

POSTED CONTENT published

Authors: Bhanu Prakash Reddy Attunuru | Podduturi Naveenchander Reddy | Sasikala Mitnala | Gujjarlapudi Deepika | Sadhana Yelamanchili Veturi | Duvvur Nageshwar Reddy

https://doi.org/10.21203/rs.3.rs-1210542/v2 Actions

2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin )

JOURNAL ARTICLE published 27 November 2023 in Open Forum Infectious Diseases

Authors: Debdeep Mitra | Neerja Saraswat

https://doi.org/10.1093/ofid/ofad500.1992 Actions

Covaxin (BBV152) Vaccine Neutralizes SARS-CoV-2 Delta and Omicron variants

POSTED CONTENT published

Authors: Venkata-Viswanadh Edara | Mit Patel | Mehul S. Suthar

https://doi.org/10.1101/2022.01.24.22269189 Actions

Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran

JOURNAL ARTICLE published December 2021 in International Immunopharmacology

Research funded by Birjand University of Medical Sciences (5653)

Authors: Hamed Zare | Hadis Rezapour | Sara Mahmoodzadeh | Mohammad Fereidouni

https://doi.org/10.1016/j.intimp.2021.108351 Actions

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic

JOURNAL ARTICLE published 2021 in Journal of Family Medicine and Primary Care

Authors: SunilKumar Raina | Raman Kumar

https://doi.org/10.4103/jfmpc.jfmpc_174_21 Actions

Adverse Events among Beneficiaries who Received a Dose of Sputnik V Vaccine at a Tertiary Care Hospital in Coastal Karnataka, India

JOURNAL ARTICLE published 2023 in Indian Journal of Community Medicine

Authors: Basma R. Ameer | Kibballi Madhukeshwar Akshaya | Madhavi Bhargava | Jeshela Jamal

https://doi.org/10.4103/ijcm.ijcm_777_22 Actions

A Comparison of Adverse Reactions of the First Dose of Gam-COVID-vac (Sputnik V), Oxford/AstraZeneca COVID-19 Vaccine, Bharat Biotech (Covaxin), and (Sinopharm) BBIBP-CorV Vaccines

JOURNAL ARTICLE published 10 November 2022 in Journal of Health Reports and Technology

Authors: HamidReza Samimagham | Mehdi Hassani Azad | Mohsen Arabi | Sobhan Montazer Ghaem | Kimiya Jafari | Dariush Hooshyar | Mitra Kazemi Jahromi

https://doi.org/10.5812/jhrt-122479 Actions
Feedback: support@crossref.org